Blood safety and availability: Continuing challenges in China's blood banking system

Transfusion

Volumn 54, Issue 2, 2014, Pages 471-482

  Shi, Ling ^a   Wang, Jing Xing ^a   Stevens, Lori ^a   Ness, Paul ^a   Shan, Hua ^a  

^a UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD BANKS; BLOOD DONORS; BLOOD SAFETY; CHINA; HIV INFECTIONS; HUMANS; RISK FACTORS; SYPHILIS;

EID: 84893941956     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12273     Document Type: Review

References (106)

1. Shan H, Wang JX, Ren FR, Zhang YZ, Zhao HY, Gao GJ, Ji Y, Ness PM,. Blood banking in China. Lancet 2002; 360: 1770-1775.
2. Lu L, Jia M, Ma Y, Yang L, Chen Z, Ho DD, Jiang Y, Zhang L,. The changing face of HIV in China. Nature 2008; 455: 609-611.
3. Yan J, Zheng X, Zhang X, Liu S, Zhang Y, Wang C,. [The survey of prevalence of HIV infection among paid blood donors in one county in China]. Zhonghua Liu Xing Bing Xue Za Zhi 2000; 21: 10-13. Chinese.
4. Ministry of Health People's Republic of China, Joint United Nations Programme on HIV/AIDS, WHO. 2011 estimates for the HIV/AIDS epidemic in China. Beijing: Ministry of Health of the People's Republic of China, 2011.
5. Gao F,. Meeting the challenges in China. Transfus Int 2000; 79: 10-11.
6. Wang Y,. Blood banking management in China. A report in the Fifth National Conference of Chinese Society of Blood Transfusion. 2010.
7. Ministry of Health People's Republic of China. Progress report of unpaid voluntary blood donation in China. Beijing: Ministry of Health of the People's Republic of China; 2012.
8. Chen X, Chen C, Zhang Y, Yuan Y, Ye J,. The effect of health insurance reform on the number of cataract surgeries in Chongqing, China. BMC Health Serv Res 2011; 11: 67-70.
9. World Health Organization. Blood safety and availability. Facts and figures from the 2007 Blood Safety Survey. Geneva: World Health Organization; 2009.
10. Wang J, Guo N, Guo X, Li J, Wen GX, Yang T, Yun Z, Huang Y, Schreiber GB, Kavounis K, Ness P, Shan H,; National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II (REDS-II)-International Component. Who donates blood at five ethnically and geographically diverse blood centers in China in 2008. Transfusion 2010; 50: 2686-2694.
11. Yu X, Huang Y, Qu G, Xu J, Hui S,. Safety and current status of blood transfusion in China. Lancet 2010; 375: 1420-1421.
12. Department of Health and Human Services. The 2009 national blood collection and utilization survey. Washington, DC: Department of Health and Human Services; 2011.
13. Whitsett C, Vaglio S, Grazzini G,. Alternative blood products and clinical needs in transfusion medicine. Stem Cells Int 2012; 2012: 639561.
14. World Health Organization. Blood safety: key global fact and figures in 2011. Geneva: World Health Organization; 2011.
15. Shen XY, Gui WJ, Fu Q,. [Investigation on voluntary blood donation and clinical transfusion in Nanjing]. Yi Yao Qian Yan 2012; 19: 140-141. Chinese.
16. Yu XR, Chen MY,. [Addressing the causes of blood supply shortage]. Med J Peking Union Med Coll Hosp 2011; 1: 11-12. Chinese.
17. Di YW, Cui HY,. [Causes and Coping Strategies for Blood Supply Shortage in Huhhot]. Zhong Hua Xian Dai Lin Chuang Yi Xue Za Zhi 2011; 9: 10. Chinese.
18. Huang J, Millis JM, Mao Y, M Andrew M, Sang X, Zhong S,. A pilot programme of organ donation after cardiac death in China. Lancet 2012; 379: 862-865.
19. Zhang L, Wang J, Kwauk S, Wu Q, Nielson K, Zeng F, Bai M, Wang C,. Preliminary analysis of factors influencing organ donation rates in China. Transplant Proc 2011; 43: 1421-1424.
20. Wu XZ, Jiang YS,. [Effect of platelet apheresis on the frozen and storage of blood platelet]. Nan Tong Yi Xue Yuan Xue Bao 2004; 24: 519-521. Chinese.
21. Guo N, Wang J, Ness P,. Demographics of apheresis platelet donors in five blood centers in China. Transfusion 2012; 52: 560-566.
22. Yang PQ,. [Recruitment of apheresis platelet donors]. Jian Yan Yi Xue Yu Li Chuang 2012; 9: 895-896. Chinese.
23. Liu YL,. [Analysis on psychosocial factors influencing apheresis platelet donations]. Zhong Guo Shu Xue Za Zhi 2010; S1: 29. Chinese.
24. Zhou J, Zhu LY, Zheng HX,. [Recruiting college students as apheresis platelet donors]. Lin Chuang Xue Ye Xue Za Zhi 2012; 1: 115-116. Chinese.
25. Mao GP, Wang YS,. [Causes for clinical blood supply shortage]. J Clin Tr Ansfus Lab Med 2011; 13: 374-376.
26. YM L,. [Investigation on blood donors in Changsha]. J Clin Tr Ansfus Lab Med 2007; 9: 15-17.
27. Meng Y,. [Examining the implementation of the Blood Donation Law from the phenomenon of seasonal blood supply shortage]. China Health Law 2012; 20: 59-61.
28. Jia YZ, Wei W,. [Reducing blood donation reaction and improving clinical blood utilization]. Zhong Hua Zhong Xi Yi Za Zhi 2005; 6: 11-12. Chinese.
29. Reynolds L, McKee M,. Matching supply and demand for blood in Guizhou province, China: an unresolved challenge. J Public Health (Oxf) 2010; 32: 103-109.
30. Adams V, Erwin K, Le PV,. Public health works: blood donation in urban China. Soc Sci Med 2009; 68: 410-418.
31. Zaller N, Nelson KE, Ness P, Wen G, Kewir T, Bai X, Shan H,. Demographic characteristics and risks for transfusion-transmissible infection among blood donors in Xinjiang autonomous region, People's Republic of China. Transfusion 2006; 46: 265-271.
32. Zaller N, Nelson KE, Ness P, Wen G, Bai X, Shan H,. Knowledge, attitude and practice survey regarding blood donation in a Northwestern Chinese city. Transfus Med 2005; 15: 277-286.
33. Zhou JQ,. [Exploring causes for blood supply shortage]. Zhong Guo Shi Yong Yi Yao 2012; 7: 264-265. Chinese.
34. Yan Z, Xu YS, Wang YM,. [Coping strategy for the trust crisis in blood donation]. Zhong Guo Shu Xue Za Zhi 2012; S1: 194. Chinese.
35. Zheng QL,. [Use blood collection mobiles in rural areas to recruit blood donors]. Zhong Guo Shu Xue Za Zhi 2007; 20: 534-535. Chinese.
36. Guo N, Wang J, Ness P, Yao F, Dong X, Bi X, Mei H, Li J, He W, Lu Y, Ma H, Wen X, Huang M, Wright DJ, King M, High P, Nelson K, Shan H,; NHLBI Retrovirus Epidemiology Donor Study-II, International Component. Analysis of Chinese donors' return behavior. Transfusion 2011; 51: 523-530.
37. Liu J, Huang Y, Wang J, Bi X, Li J, Wen X, Yao F, Dong X, He W, Huang M, Ma H, Mei H, King M, Wright DJ, Ness PM, Shan H,; REDS II International China Study. Impact of the May 12, 2008, earthquake on blood donations across five Chinese blood centers. Transfusion 2010; 50: 1972-1979.
38. Guo N, Wang J, Ness P, Yao F, Bi X, Li J, Yun Z, Guo X, Huang Y, Dong X, Tiemuer MH, He W, Ma H, Huang M, Liu J, Wright DJ, Nelson K, Shan H,; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) International Component. First-time donors responding to a national disaster may be an untapped resource for the blood centre. Vox Sang 2012; 102: 338-344.
39. Ministry of Health People's Republic of China. Health examination criteria of blood donors. Beijing: Ministry of Health of the People's Republic of China; 2012.
40. Simon TL, Rhyne RL, Wayne SJ, Garry PJ,. Characteristics of elderly blood donors. Transfusion 1991; 31: 693-697.
41. Cable R, Glynn S, Kiss J, Mast AE, Steele WR, Murphy EL, Wright DJ, Sacher RA, Gottschall JL, Tobler LH, Simon TL,; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion 2012; 52: 702-711.
42. Tian GL, Wen HL,. [Analysis on component transfusions in clinical utilization]. Bao Tou Yi Xue Yuan Xue Bao 2010; 26: 5. Chinese.
43. Qian YQ,. [Component transfusion application in a hospital]. Jian Yan Yi Xue Yu Lin Chuang 2012; 9: 1113-1114. Chinese.
44. Liu LW,. [Investigation on clinical utilization of blood in primary hospitals]. Jian Yan Yi Xue Yu Lin Chuang 2009; 6: 1792-1793. Chinese.
45. Peng GP, Wu LJ, Duan L, Shu Y,. [Analysis on component transfusion in Ji An City]. Jiang Xi Yi Xue Jian Yan 2006; 24: 373. Chinese.
46. Ren MW,. [Use of autologous blood transfusion to address blood supply shortage with a national blood donation rate of 0.87%]. Zhong Guo Yi Liao Bao Xian Za Zhi 2012; 2: 9. Chinese.
47. Yang B, Kong L, Shao C,. Review of 2597 cases of blood transfusion and evaluation of the appropriateness. Chin J Blood Transfus 2008; 21: 193-197.
48. Luk C, Eckert K, Barr R,. Prospective audit of the use of fresh-frozen plasma, based on Canadian Medical Association transfusion guidelines. CMAJ 2002; 166: 1539-1540.
49. Schofield W, Rubin G, Dean M,. Appropriateness of platelet, fresh frozen plasma and cryoprecipitate transfusion in New South Wales public hospitals. Med J Aust 2003; 178: 117-121.
50. Zhu YG, He JJ, Cao HL,. [Investigation on transfusion divisions in tertiary hospitals in Shanghai]. Zhong Guo Wei Sheng Zi Yuan 2012; 15: 311-313. Chinese.
51. Zhuang L, Zhu XD, Zhang Z, Huang CS, Cao W,. [Investigation on autologous transfusion rates at different hospitals]. Shang Hai Yu Fang Yi Xue 2008; 20: 392-393. Chinese.
52. Liu C, Jiang JM, Zhang YW,. [Causes for extremely low autologous transfusion rate in primary hospitals]. Jian Yan Yi Xue Yu Lin Chuang 2011; 8: 1271-1272. Chinese.
53. Shander A, Javidroozi M, Perelman S, Puzio T, Lobel G,. From bloodless surgery to patient blood management. Mt Sinai J Med 2012; 79: 56-65.
54. Wei RL,. [Information system management in blood centers]. Zhong Guo Shu Xue Za Zhi 2012; S1: 230. Chinese.
55. Ministry of Health People's Republic of China. National report on infectious diseases. Beijing: Ministry of Health of the People's Republic of China; 2008.
56. Qian HZ, Vermund SH, Wang N,. Risk of HIV/AIDS in China: subpopulations of special importance. Sex Transm Infect 2005; 81: 442-447.
57. Wang L, Wang N, Li D, Li D, Jia M, Gao X, Qu S, Qin Q, Wang Y, Smith K,. The 2007 estimates for people at risk for and living with HIV in China: progress and challenges. J Acquir Immune Defic Syndr 2009; 50: 414-418.
58. Chinese National Center for Disease Control and Prevention. Annual report of National AIDS/STD Surveillance in 2002: analysis of HIV epidemic in 2002. Beijing: Chinese National Center for Disease Control and Prevention; 2003. p. 6-9.
59. State Council AIDS Working Committee Office, UN Theme Group on AIDS in China. A joint assessment of HIV/AIDS prevention, treatment and care in China (2007). Beijing: China Ministry of Health; 2007.
60. Sun XH, Lu F, Wu ZY, Poundstone K, Zeng G, Xu P,. Evolution of information-driven HIV/AIDS policies in China. Int J Epidemiol 2010; 39: ii4-ii13.
61. Zhang Y, Wang D, Li G, Gu Y, Jackson B, Shan H,. Results of HIV testing among blood donors in Xinjiang, China. The 53rd Annual Meeting of American Association of Blood Bankers, October 2000, Washington, DC.
62. Tan Q, Chen X, Li J,. [Seropositive prevalence among unpaid donors]. Lin Chuang Shu Xue Yu Jian Yan 2009; 2: 145-147. Chinese.
63. Yin P, Lv Y, Zhong L, Tao X,. [The results of blood screening in blood donors of Hunan in 1997-2002]. Shi Yong Yu Fang Yi Xue 2004; 11: 1. Chinese.
64. Li Y, Zheng H, Xiao S,. [HIV seropositive rate among unpaid donors in Guangzhou]. Zhong Guo Shu Xue Za Zhi 2003; 16: 276. Chinese.
65. Meng Z, Yang J, Zhou H, Yan L,. [Retrospective study on HIV infection among blood donors in Zhejiang Province over 11-year period (1993-2004)]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006; 14: 1231-1233. Chinese.
66. Wang J, Liu J, Yao FZ, Wen G, Li J, Huang Y, Lü Y, Wen X, Wright D, Yu Q, Guo N, Ness P, Shan H,; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) and International Component. Prevalence, incidence, and residual risks for transfusion transmitted HIV-1/2 infection among Chinese blood donors. Transfusion 2013; 53: 1240-1249.
67. Zhang H, Li Q, Sun J, Wang C, Gu Q, Feng X, Du B, Wang W, Shi X, Zhang S, Li W, Jiang Y, Feng J, He S, Niu J,. Seroprevalence and risk factors for hepatitis B infection in an adult population in Northeast China. Int J Med Sci 2011; 8: 321-331.
68. Ouyang L, Huang CH, Wang XL, He XH, Li XL,. [Application of HBsAg pre-donation rapid testing in blood donation screening]. Lin Chuang Shu Xue Yu Jian Yan 2003; 1: 55-56. Chinese.
69. Yang YL, Fu Q, Zhang MS, Cai J, Ma GM, Huang ZH, Cai XB,. Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China. Virol J 2012; 9: 82.
70. Lau G, Zhuang H,. Top hepatology issues in China. J Gastroent Hepatol 2002; 17: A9.
71. Zhuang H,. [HCV research deserves attention]. Chin J Liver Dis 2004; 16: 49-57. Chinese.
72. Yu Z,. [The rate of anti-HCV among different types of blood donors]. Zhong Guo Ji Bing Kong Zhi Za Zhi 1998; 3: 71. Chinese.
73. Gao X, Cui Q, Shi X, Su J, Peng Z, Chen X, Lei N, Ding K, Wang L, Yu R, Wang N,. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infect Dis 2011; 11: 88.
74. Zhang ZW, Shimbo S, Qu JB, Liu ZM, Cai XC, Wang LQ, Watanabe T, Nakatsuka H, Matsuda-Inoguchi N, Higashikawa K, Ikeda M,. Hepatitis B and C virus infection among adult women in Jilin Province, China: an urban-rural comparison in prevalence of infection markers. Southeast Asian J Trop Med Public Health 2000; 31: 530-536.
75. Qu JB, Zhang ZW, Shimbo S, Watanabe T, Nakatsuka H, Matsuda-Inoguchi N, Higashikawa K, Ikeda M,. Urban-rural comparison of HBV and HCV infection prevalence in eastern China. Biomed Environ Sci 2000; 13: 243-253.
76. Fu Y, Xia W, Wang Y, Tian L, Pybus OG, Lu L, Nelson K,. The seroprevalence of hepatitis C virus (HCV) among 559,890 first-time volunteer blood donors in China reflects regional heterogeneity in HCV prevalence and changes in blood donor recruitment models. Transfusion 2010; 50: 1505-1511.
77. Zhao SM, Jiang TL, Li RQ, Gao FX, Lu L, Zheng HQ, Hu J, Fan YH, Li B, Xiao RQ, Yury K,. [HCV infection in voluntary donors and its influence on recruitment of donors in Chongqing area]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008; 16: 676-680. Chinese.
78. Yue QH, Zhang XQ, Shang Y, Chen YZ, Sun WL, Su MQ, Mu SJ, Hao XK, Hu XB,. Anti-HCV reactive volunteer blood donors distribution character and genotypes switch in Xi'an, China. Virol J 2010; 7: 186.
79. Lu YF, Yin P, Liu TY,. [Analysis on quality control of blood in blood banks in a five-year program in Hunan province]. Zhonghua Liu Xing Bing Xue Za Zhi 2003; 24: 574-576. Chinese.
80. Ministry of Health People's Republic of China. Chinese health statistical digest. 2012. Beijing: Ministry of Health of the People's Republic of China; 2012.
81. Hesketh T, Zhu W, Zhou X,. Syphilis and social upheaval in China: author reply. N Engl J Med 2010; 363: 1088-1089.
82. Centers for Disease Control and Prevention. HIV infection: Guangdong Province, China, 1997-2007. MMWR Morb Mortal Wkly Rep 2009; 58: 396-400.
83. Pan X, Zhu Y, Wang Q, Zheng H,. Prevalence of HIV, syphilis, HCV and their high risk behaviors among migrant workers in Eastern China. Plos ONE 2013; 8: e57258.
84. Li WH, Peng GY, Yang F,. [Causes for the rapid rise in syphilis and accuracy in syphilis reporting at medical institutes in Hubei]. Chin J Leprosy Skid Dis 2012; 4: 280-281. Chinese.
85. Liu J, Huang Y, Wang J, Guo N, Li J, Dong X, Ma H, Tiemuer M, Huang M, Wright DJ, Ness P, Shan H,; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component. The increasing prevalence of serologic markers for syphilis among Chinese blood donors in 2008 through 2010 during a syphilis epidemic. Transfusion 2012; 52: 1741-1749.
86. Wu XX, Cao QD, Ye ZY, Chen L,. Confidentiality and privacy of voluntary blood donors. Med Soc 2010; 23: 75-77.
87. Pu XH,. [How to protect blood donors' confidentiality and privacy]. Zhong Guo Xian Dai Lin Chuang Yi Xue 2007; 10: 925. Chinese.
88. Centers for Disease Control and Prevention. HIV transmission through transfusion-Missouri and Colorado, 2008. MMWR Morb Mortal Wkly Rep 2010; 59: 1335-1339.
89. Jackson BR, Busch MP, Stramer SL, AuBuchon JP,. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003; 43: 721-729.
90. Dodd RY, Notari EP, Stramer SL,. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42: 975-979.
91. Zou S, Dorsey KA, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY, Stramer SL,. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010; 50: 1495-1504.
92. Wen Y, Shan GQ, Pu JH, Zhou M,. [Preparation and clinical application of nano-piezoelectric immunosensor for combined detection of four blood transfusion transmitted diseases]. Chin J Health Lab Technol 2009; 9: 2032-2033. Chinese.
93. Wu ZJ, Sun ZX, Li B, Li QH,. [Inactivation of endotoxin using Titanium dioxide (TiO2) nanoparticles]. Zhong Guo Shu Xue Za Zhi 2007; 1: 121. Chinese.
94. Yong Y, Zhao HS, Jia LP,. [Evaluation of the domestic equipment of automatic nucleic acids extraction system with magnetic beads for the detection and pre-treatment of HBV-DNA]. Chin J Health LabTechonol 2011; 8: 1906-1908. Chinese.
95. Liu Z, Mei Z, Zheng X, Zhang W, Wang F, Zhu Y,. [Investigation on 3 cases of HIV infection in unauthorized blood collection in a middle province of China]. Zhonghua Liu Xing Bing Xue Za Zhi 2000; 21: 466-467. Chinese.
96. Jiang T, Zou W,. [Results and analysis of quality assessment programs from blood centers in Guangdong province in 1998]. Chin J Blood Transfus 2000; 13: 44-45. Chinese.
97. Liu S, Figueroa P, Rou K, Wu Z, Chen X, Detels R,. Safety of the blood supply in a rural area of China. J Acquir Immune Defic Syndr 2010; 53 Suppl 1: S23-26.
98. Shang G, Seed CR, Wang F, Nie D, Farrugia A,. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion 2007; 47: 529-539.
99. Lei W, Hu L, Gong F, Wang Y, Chen Z, Xu Z,. [Result from testing anti-HCV negative donor samples by RT-PCR]. Zhong Guo Shu Xue Za Zhi 1999; 12: 31-32. Chinese.
100. Liu Y, Luo L, Xu D, Zhang Z,. [HCV RNA testing using nested RT-PCR on donor samples]. Zhong Guo Shu Xue Za Zhi 1999; 12: 33-34. Chinese.
101. Kleinman S, King M, Busch M, Murphy E, Glynn S,; National Heart Lung Blood Institute Retrovirus Epidemiology Donor Study; Retrovirus Epidemiology Donor Study-II. The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability. Transfus Med Rev 2012; 26: 281-304.
102. Ren F, Wang J, Huang Y, Yao F, Lv YL, Li JL, Wen GX, Wen XQ, Liu J, Dong XD, Ma HL, Zhou ZM, Bi XH, Tu L, King M, Nelson K, Ness P, Shan H,. Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase. Transfusion 2011; 51: 2588-2595.
103. Zeng P, Wang J, Huang Y, Guo X, Li J, Wen G, Yang T, Yun Z, He M, Liu Y, Yuan Y, Schulmann J, Glynn S, Ness P, Jackson JB, Shan H,; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component. The human immunodeficiency virus-1 genotype diversity and drug resistance mutations profile of blood donors from five Chinese blood centers. Transfusion 2012; 52: 1041-1049.
104. World Health Organization. Global database on blood safety. Summary report 2011. Geneva: World Health Organization; 2011.
105. Lee R,. The demographic transition: three centuries of fundamental change. J Econ Perspect 2003; 17: 167-190.
106. Davidson T, Ekermo B, Gaines H, Lesko B, Akerlind B,. The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden. Transfusion 2011; 51: 421-429.